[
    {
        "trialName": "Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory Medications",
        "nctNumber": "NCT02583672",
        "statusVerifiedDate": "2023-12",
        "overallStatus": "RECRUITING",
        "startDate": "2015-09",
        "primaryCompletionDate": "2025-07-31",
        "completionDate": "2025-07-31",
        "studyFirstSubmitDate": "2015-08-21",
        "lastUpdateSubmitDate": "2023-12-21",
        "startDateType": "ACTUAL",
        "durationDays": 3621,
        "daysUntilEnd": 353
    },
    {
        "trialName": "Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States",
        "nctNumber": "NCT05908656",
        "statusVerifiedDate": "2024-04",
        "overallStatus": "RECRUITING",
        "startDate": "2024-04-02",
        "primaryCompletionDate": "2024-07-23",
        "completionDate": "2024-07-23",
        "studyFirstSubmitDate": "2023-06-08",
        "lastUpdateSubmitDate": "2024-04-03",
        "startDateType": "ACTUAL",
        "durationDays": 112,
        "daysUntilEnd": -20
    },
    {
        "trialName": "Gaucher Disease Registry Protocol",
        "nctNumber": "NCT00358943",
        "statusVerifiedDate": "2024-04",
        "overallStatus": "RECRUITING",
        "startDate": "1991-04-01",
        "primaryCompletionDate": "2034-01-31",
        "completionDate": "2034-01-31",
        "studyFirstSubmitDate": "2006-07-12",
        "lastUpdateSubmitDate": "2024-04-15",
        "startDateType": "ACTUAL",
        "durationDays": 15646,
        "daysUntilEnd": 3459
    },
    {
        "trialName": "Drug Discovery for Parkinson's With Mutations in the GBA Gene",
        "nctNumber": "NCT05536388",
        "statusVerifiedDate": "2024-07",
        "overallStatus": "RECRUITING",
        "startDate": "2022-07-15",
        "primaryCompletionDate": "2025-07-15",
        "completionDate": "2025-07-15",
        "studyFirstSubmitDate": "2022-09-07",
        "lastUpdateSubmitDate": "2024-07-26",
        "startDateType": "ACTUAL",
        "durationDays": 1096,
        "daysUntilEnd": 337
    },
    {
        "trialName": "A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)",
        "nctNumber": "NCT04127578",
        "statusVerifiedDate": "2024-06",
        "overallStatus": "RECRUITING",
        "startDate": "2020-01-03",
        "primaryCompletionDate": "2029-06",
        "completionDate": "2029-06",
        "studyFirstSubmitDate": "2019-10-14",
        "lastUpdateSubmitDate": "2024-06-18",
        "startDateType": "ACTUAL",
        "durationDays": 3437,
        "daysUntilEnd": 1754
    }
]